Found: 5
Select item for more details and to access through your institution.
DNDI-6174 is a preclinical candidate for visceral leishmaniasis that targets the cytochrome bc<sub>1</sub>.
- Published in:
- Science Translational Medicine, 2023, v. 15, n. 726, p. 1, doi. 10.1126/scitranslmed.adh9902
- By:
- Publication type:
- Article
Combined Liquid Chromatography-mass Spectrometry and Next-generation DNA Sequencing Detection of Adulterants and Contaminants in Analgesic and Anti-inflammatory Herbal Medicines.
- Published in:
- Pharmaceutical Medicine, 2020, v. 34, n. 1, p. 49, doi. 10.1007/s40290-019-00314-y
- By:
- Publication type:
- Article
Adulterants and Contaminants in Psychotropic Herbal Medicines Detected with Mass Spectrometry and Next-Generation DNA Sequencing.
- Published in:
- Pharmaceutical Medicine, 2018, v. 32, n. 6, p. 429, doi. 10.1007/s40290-018-0252-8
- By:
- Publication type:
- Article
An in vitro toolbox to accelerate anti-malarial drug discovery and development.
- Published in:
- Malaria Journal, 2020, v. 19, n. 1, p. 1, doi. 10.1186/s12936-019-3075-5
- By:
- Publication type:
- Article
The application of metabolomics for herbal medicine pharmacovigilance: a case study on ginseng.
- Published in:
- Essays in Biochemistry, 2016, v. 60, n. 5, p. 429, doi. 10.1042/EBC20160030
- By:
- Publication type:
- Article